Migdal Insurance & Financial Holdings Ltd. Has $62.20 Million Holdings in SPDR S&P Biotech ETF $XBI

Migdal Insurance & Financial Holdings Ltd. lessened its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 28.6% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 750,000 shares of the exchange traded fund’s stock after selling 300,000 shares during the period. Migdal Insurance & Financial Holdings Ltd.’s holdings in SPDR S&P Biotech ETF were worth $62,198,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently bought and sold shares of the company. DHJJ Financial Advisors Ltd. purchased a new position in SPDR S&P Biotech ETF during the 2nd quarter valued at about $25,000. Garrison Bradford & Associates Inc. purchased a new position in SPDR S&P Biotech ETF during the 1st quarter valued at about $39,000. Quaker Wealth Management LLC grew its stake in SPDR S&P Biotech ETF by 101.2% during the 2nd quarter. Quaker Wealth Management LLC now owns 623 shares of the exchange traded fund’s stock valued at $52,000 after acquiring an additional 53,536 shares in the last quarter. Compass Wealth Management LLC grew its stake in SPDR S&P Biotech ETF by 46.0% during the 1st quarter. Compass Wealth Management LLC now owns 635 shares of the exchange traded fund’s stock valued at $51,000 after acquiring an additional 200 shares in the last quarter. Finally, Golden State Wealth Management LLC grew its stake in SPDR S&P Biotech ETF by 100.0% during the 1st quarter. Golden State Wealth Management LLC now owns 638 shares of the exchange traded fund’s stock valued at $52,000 after acquiring an additional 319 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

NYSEARCA:XBI opened at $112.00 on Wednesday. SPDR S&P Biotech ETF has a fifty-two week low of $66.66 and a fifty-two week high of $112.43. The stock’s 50-day moving average is $98.97 and its two-hundred day moving average is $88.51. The stock has a market cap of $6.87 billion, a PE ratio of 11.47 and a beta of 0.93.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.